Call them the Johnson & Johnson 16 million.
That’s the number of Americans who got the one-shot vaccine as their first COVID-19 dose and now find themselves in a gray zone. While health officials encourage those who’ve gotten the double-dose Pfizer-BioNTech or Moderna series to get a third shot, J&J recipients are limited to their original one and a single booster.
‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort